NR3C2 and COVID-19: MR-proANP was a significant, independent predictor of 28-day mortality, even after adjustment for clinical confounders, comorbidities, and established prognostic markers for COVID-19 (HR, 2.77; 95% CI, 1.21–6.37; p = 0.016).